Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced HES 130/0.42 in Elderly Cardiac Surgery Patients
NCT00576849Phase 4Completed
- Sponsor
- Klinikum Ludwigshafen
- Start
- Dec 2007
- Primary completion
- May 2010
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydroxyethyl starch 130/0.42 in hypovolemia (2 arms), sponsored by Klinikum Ludwigshafen. Primary endpoint: Postoperative renal function at 28 days. Started Dec 2007; status: completed.
02
Drugs
hydroxyethyl starch 130/0.42
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT00576849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00576849.